Facebook
Twitter
LinkedIn
ForwardAdvanced Bugs and Drugs (Self-Study)
Target Audience
Ideal for medical students, residents, fellows and others who desire to expand their knowledge of key microbiology and pharmacology concepts. This course can be used collaboratively in a classroom setting, or completed independently. Please reach out to academy@idsociety.org for more information about how to best utilize this curriculum for your particular needs.
Learning Objectives
Module 1: Drugs Foundation
Module 2: The Steward's Corner
Module 3: Case 1 - KPC
Module 4: Case 2 - Invasive Candidiasis
Module 5: Case 3 - HSV
Microbiological Learning Objectives
- Discuss rapid diagnostic and resistance/susceptibility testing principles most important to pathogens relevant to stewardship (KPC, Candida spp, HSV).
- Describe principles of phenotypic susceptibility testing, MIC interpretation and apply practical CLSI data effectively relevant to cases (KPC, Candida spp. HSV).
- Outline opportunities for integration of microbiology lab into antimicrobial stewardship initiatives (relevant to both susceptibility testing/reporting and rapid diagnostics/lab stewardship)
Pharmacotherapeutics Learning Objectives
- Customize antimicrobial agent selection based on available phenotypic and/or genotypic microbiological testing results.
- Customize antimicrobial dosage regimens based on available phenotypic and/or genotypic microbiological testing results
- Apply PK/PD data, target indices, and therapeutic drug monitoring to the design of appropriate antimicrobial regimens for patients with altered pharmacokinetics and/or in special populations.
| Name | Individual's role in activity | Name of commercial interest | Nature of Relationship |
| Al Lawati, Hawra | Workgroup Member | None | |
| Babiker, Ahmed | Panelist | N/A | N/A |
| Beeler, Cole | Workgroup Member | None | |
| Bennani, Kenza | Staff | None | |
| Brennan - Krohn, Thea | Workgroup Member | None | |
| Bryson - Cahn, Chloe | Workgroup Member | None | |
| Fong, Gary | Workgroup Member | Critical Innovations, LLC | Advisory/Consultant Role |
| Gaston, David C | Panelist | Illumina, Inc | Research reagents |
| IDbyDNA, Inc | Research reagents | ||
| bioMerieux, Inc | Scientific advisory board | ||
| Huang, Misha | Workgroup Member | None | |
| Humphries, Romney | Panelist | bioMerieux IHMA Melinta Merck Pattern Qiagen QPex Roche Specific Torus | Consulting |
| bioMerieux Qiagen Momentum Specific Diagnostics Pattern IHMA | Research funding | ||
| Justo, Julie Ann | Workgroup Member | bioMerieux | Other remuneration - Speaker's Bureau |
| Merck | Advisory/Consultant Role | ||
| Vaxart | Stocks/Bonds | ||
| Kang, Amy | Workgroup Member | None | |
| Logan, Ashleigh | Staff | None | |
| Luther, Vera | Workgroup Member | None | |
| MacDougall, Conan | Workgroup Member | None | |
| Miller, Matt | Workgroup Member | Abbvie | Honoraria |
| La Jolla | Honoraria | ||
| Merck | Research Grant/Contract | ||
| Moenster, Ryan | Workgroup Member | Shionogi | Advisory/Consultant Role, Honoraria |
| Abbvie/Allergan | Advisory/Consultant Role, Honoraria | ||
| Melinta Therapeutics | Advisory/Consultant Role, Honoraria | ||
| Merck | Advisory/Consultant Role, Honoraria | ||
| Nori, Priya | Workgroup Chair | Merck | Co-infections in COVID-19 patients |
| Paras, Molly | Workgroup Member | None | |
| Rodvold, Keith | Workgroup Member | BLC USA LP | Advisory/Consultant Role, Honoraria |
| VenatoRx | Advisory/Consultant Role, Honoraria | ||
| Medicine Company/Qpex Biopharma | Advisory/Consultant Role, Honoraria | ||
| Vemco Med Ed. (Merck CME/CPE programs) | Advisory/Consultant Role, Honoraria | ||
| Debipharm | Advisory/Consultant Role, Honoraria | ||
| Shionogi | Advisory/Consultant Role, Honoraria | ||
| Unrestricted education grant for CME/CPE Program | |||
| Utility Therapeutics | Advisory/Consultant Role, Honoraria | ||
| Janssen | Data Safety Monitoring Board (DSMB) | ||
| Clinartis LLC (projects associated with Spero Therapeutics and Sinovent) | Advisory/Consultant Role, Honoraria | ||
| USCAST : US Ctte on Antimicrobial Susceptibility Testing | Voting Committee Member | ||
| Spicer, Jennifer | Workgroup Member | None | |
| Stead, Wendy | Workgroup Member | None | |
| Stohs, Erica | Workgroup Member | Reviral Ltd | Research Grant |
| Shnekendorf, Rachel | Staff | None | |
Vaezi, Liza | Workgroup Member | None | |
| Williams, Rostam | Staff | None |
This version of the curriculum is not accredited for CME or MOC.